We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
351
Warner Bros
WBD
$66.2B
-1,350
Closed -$41K
XLU icon
352
State Street Utilities Select Sector SPDR ETF
XLU
$22.4B
-200
Closed -$6K
UFOX
353
Defiance Space and Connective Tech ETF
UFOX
$885M
$0 ﹤0.01%
3
BNT
354
Brookfield Wealth Solutions
BNT
$12.2B
-303
Closed -$11K
BSCO
355
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
-500
Closed -$11K
MRO
356
DELISTED
Marathon Oil Corporation
MRO
-36,750
Closed -$501K
VRTV
357
DELISTED
VERITIV CORPORATION
VRTV
-9
Closed -$1K
ARNC
358
DELISTED
Arconic Corporation
ARNC
$0 ﹤0.01%
11

Similar funds

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.